Profile banner
Constant Beroulle

Constant Beroulle

HealthTech VC @Newfund | Pharm.D. & MiM

constant-beroulle
Paris, Île-de-France, France
Joined February 2026

Network

9.2K connections

Summary

Constant Beroulle is a HealthTech VC at Newfund, actively involved in the firm's BrainTech-focused vehicle, Heka. He leads investments in the Nordic countries and contributes to supporting early-stage healthtech companies like AI-Stroke, which develops AI-powered stroke triaging solutions. His role involves assessing market potential and providing strategic insights to startups in the healthcare technology sector. theorg+3
Constant demonstrates expertise in the BrainTech market, evidenced by his extensive writings on the Newfund Capital blog. His articles cover diverse topics including Brain-Computer Interfaces, Techbio applications in BrainTech, SleepTech, Psychedelics, and skills enhancement startups, reflecting a deep understanding of emerging trends and investment opportunities in the brain technology space. newfundcap+7
With a dual background in Pharmacy (Pharm.D.) and Management (M.Sc. from emlyon business school), Constant brings a unique interdisciplinary perspective to his work. His academic training included a focus on regulatory aspects and market access for innovative medical devices, which is directly applicable to his investments in health technology startups. His early experience as a co-founder of Transipharm also highlights his entrepreneurial drive. theorg+3

Work

Education

Writing

Psychedelics: an investor perspective

March 1, 2025

An article from a series on the BrainTech market, focusing on the psychedelic market and its renaissance over the past decade.

Favicon imageblog.newfundcap.com

Brain-Computer Interfaces: The Latest Breakthroughs and Developments

July 1, 2024

An article discussing the advancements and importance of brain-computer interfaces (BCIs), selected as technology of the year by Nature Electronics.

Favicon imageblog.newfundcap.com

Techbio and its applications in BrainTech: an investor perspective

April 1, 2024

Part of a series on the BrainTech market, this article explores the current state of Techbio and its applications in BrainTech from an investor's point of view.

Favicon imageblog.newfundcap.com

Exploring Opportunities in the Nordic Countries

December 1, 2023

Discusses Newfund Heka's expansion of geographic scope to the Nordic countries for BrainTech-focused investments.

Favicon imageblog.newfundcap.com

Skills enhancement startups: an investor point of view

December 1, 2023

Examines skills enhancement startups as part of a series on the BrainTech market, offering an investor's perspective.

Favicon imageblog.newfundcap.com

The SleepTech Industry: an Investor Perspective

October 1, 2023

A detailed look into the SleepTech industry, defining the sector and providing an investor's perspective.

Favicon imageblog.newfundcap.com

Brain Computer Interface : an investor perspective

March 1, 2023

Explores BrainTech as an emerging sector of innovation, specifically focusing on Brain Computer Interfaces (BCI) from an investor's perspective.

Favicon imageblog.newfundcap.com